The Serum/Glucocorticoid-Regulated Kinase 1 Is Targeted by miR-19a in CD4+ T Cells

Cells. 2022 Dec 29;12(1):133. doi: 10.3390/cells12010133.

Abstract

The polarization of CD4+ T cells into different T helper subsets is an important process in many diseases, including asthma. Part of the adaptive immune system, T cells are responsible for propagating signals to alert and prime the immune system. MicroRNAs (miRNAs) are small non-coding RNAs that act on numerous targets in the cell to regulate a variety of cellular processes, including roles in T cell polarization. In this study, we aimed to identify genes dysregulated in peripheral blood mononuclear cells from individuals with asthma. Moreover, we sought to examine miRNAs that may regulate the candidate genes and explore their functional relationship. Utilizing a focused gene array, we identified the serum/glucocorticoid-regulated kinase 1 (SGK1) gene to be upregulated in circulating peripheral blood mononuclear cells, which included T cells, from individuals with asthma. Several miRNAs were bioinformatically identified to target SGK1, but miR-19a was the only screened candidate that negatively correlated to SGK1 expression. Further analysis of the miR-19a-SGK1 relationship showed a negative correlation in CD4+ T cells in situ and direct binding in vitro during T cell activation. Moreover, we observed a negative correlation of miR-19a and SGK1 during early type 2 polarization of CD4+ naïve human T cells. Thus, we suggest that miR-19a has a role in binding and regulating SGK1 transcript levels during T cell development.

Keywords: CD4+ cells; T cell polarization; asthma; gene expression; microRNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD4-Positive T-Lymphocytes* / metabolism
  • Cell Differentiation
  • Glucocorticoids
  • Humans
  • Leukocytes, Mononuclear / metabolism
  • MicroRNAs* / metabolism

Substances

  • Glucocorticoids
  • MicroRNAs
  • serum-glucocorticoid regulated kinase

Grants and funding

This work was supported by the Herman Krefting Foundation, the Swedish Heart and Lung Foundation (20190378), the Swedish Research Council (202001815), Koncul Th. C. Berghs foundation, the Cancer and Allergy Foundation and an ALF/LUA research grant (ALFGBG-822751) from Sahlgrenska University Hospital.